Jaguar Health, Inc. is on the Cruelty Free Investing use of animals list because they use animals for drug testing and clinical trials.
The company stated in the following report that they conduct pre-clinical trials of their drugs on animals.
“In April 2016, we announced that standard drug testing in race horses having received Equilevia did not detect any substances commonly disallowed by horse racing authorities. ” (Page 2) Read the following document
Jaguar Health, Inc. engages in the development and commercialization of gastrointestinal products for companion and production animals. Its product, Canalevia, is the company’s prescription drug product candidate for the treatment of various forms diarrhea in dogs. It also developed its non-prescription product, Neonorm Calf, which helps dairies and beef farms proactively retain fluid in calves. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA. [Source: MarketWatch]
Company Website: https://jaguarhealth.com